Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lyell Immunopharma Inc
(NQ:
LYEL
)
1.110
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lyell Immunopharma Inc
< Previous
1
2
3
4
Next >
The Analyst Verdict: Lyell Immunopharma In The Eyes Of 4 Experts
November 12, 2024
Via
Benzinga
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024
November 07, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
November 05, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Completes Acquisition of ImmPACT Bio
October 31, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
October 30, 2024
Lyell Immunopharma acquires ImmPACT Bio, ends TIL programs, and refocuses on CAR T-cell research. Analyst downgrades reflect concerns over pipeline complexities.
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 24, 2024
Via
Benzinga
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
October 24, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 04, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
September 24, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma Announces Participation in September Investor Conferences
August 28, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q2 2024
August 08, 2024
LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
August 07, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
3 Biotech Stocks to Sell in August Before They Crash & Burn
August 06, 2024
Investors should keep a watchful eye out for these three biotech stocks to sell before a potential dip damages their gains.
Via
InvestorPlace
Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial
June 26, 2024
Lyell Immunopharma shares fell following the release of initial clinical data from its Phase 1 trial of LYL797, a reprogrammed CAR T-cell product. The company reported some severe cases reported in...
Via
Benzinga
Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
June 26, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
June 03, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
May 07, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
LYEL Stock Earnings: Lyell Immunopharma Beats EPS for Q1 2024
May 06, 2024
LYEL stock results show that Lyell Immunopharma beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
May 06, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
April 16, 2024
U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 12, 2024
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
Via
Benzinga
Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday
April 12, 2024
U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE: AGX) rose sharply during Friday’s session as the company reported better-than-expected...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 12, 2024
Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
April 11, 2024
Via
Benzinga
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
April 09, 2024
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 09, 2024
Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
Via
Benzinga
Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting
March 05, 2024
From
Lyell Immunopharma, Inc
Via
GlobeNewswire
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
March 04, 2024
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.